| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.896 | 21.072 | 33.120 | 27.644 | 27.962 | 43.856 | 49.106 | 42.548 | 44.885 |
| Total Income - EUR | - | 1.896 | 21.072 | 33.120 | 27.644 | 27.962 | 43.856 | 49.106 | 42.548 | 44.885 |
| Total Expenses - EUR | - | 0 | 8.087 | 11.479 | 10.741 | 9.824 | 19.752 | 15.745 | 21.632 | 12.837 |
| Gross Profit/Loss - EUR | - | 1.896 | 12.985 | 21.641 | 16.904 | 18.138 | 24.104 | 33.361 | 20.916 | 32.048 |
| Net Profit/Loss - EUR | - | 1.840 | 12.353 | 20.648 | 16.074 | 17.299 | 22.788 | 31.888 | 20.490 | 30.702 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Lamarmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 33.144 | 25.718 | 18.533 | 11.622 | 4.950 | 44.807 | 42.624 | 43.632 |
| Current Assets | - | 1.941 | 3.025 | 11.446 | 30.606 | 54.473 | 81.857 | 74.616 | 97.204 | 81.643 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 11.234 | 23.057 | 39.159 | 38.290 | 73.844 | 42.243 | 1 |
| Cash | - | 1.941 | 3.025 | 213 | 7.549 | 15.314 | 43.566 | 772 | 54.961 | 81.643 |
| Shareholders Funds | - | 1.884 | 14.205 | 33.492 | 48.917 | 65.289 | 86.629 | 118.785 | 138.916 | 54.995 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 57 | 21.964 | 3.672 | 222 | 806 | 177 | 638 | 912 | 70.280 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lamarmed Srl